TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

METROCREAM

METRONIDAZOLE
Immunology Approved 1995-09-20
1
Indication
--
Phase 3 Trials
30
Years on Market

Details

Status
Prescription
First Approved
1995-09-20
Routes
TOPICAL
Dosage Forms
CREAM

Companies

Active Ingredient: METRONIDAZOLE

METROCREAM Approval History

Loading approval history...

What METROCREAM Treats

1 indications

METROCREAM is approved for 1 conditions since its original approval in 1995. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Rosacea
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

METROCREAM FDA Label Details

Pro

Indications & Usage

: METROCREAM ® (metronidazole topical cream) Topical Cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.